Search research articles
Contact Us
Filters
Showing results (21-30 of 282) with videos related to
Page
of 29
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 15, 2017
Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat <i>In Vitro</i>
Owain Roberts, Saye Khoo, Andrew Owen, et al.
Drugs
|
December 15, 2010
Grapefruit-drug interactions
Kay Seden, Laura Dickinson, Saye Khoo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 16, 2024
Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir
Catia Marzolini, Sara Gibbons, Daniel Seddon, et al.
The Journal of Antimicrobial Chemotherapy
|
October 13, 2006
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
Gerald Friedland, Saye Khoo, Christopher Jack, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2011
Should we switch to a 50-mg boosting dose of ritonavir for selected protease inhibitors?
Andrew Hill, Saye Khoo, Marta Boffito, et al.
Plos Computational Biology
|
June 15, 2018
Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes
Sulav Duwal, Laura Dickinson, Saye Khoo, et al.
International Journal of STD & AIDS
|
September 27, 2013
An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database)
Mohammed I Danjuma, Nurul H Mohamad-Fadzillah, Saye Khoo
AIDS (London, England)
|
October 3, 2003
Expression of P-glycoprotein, multidrug-resistance proteins 1 and 2 in CEM, CEM(VBL), CEM(E1000), MDCKII(MRP1) and MDCKII(MRP2) cell lines
Andrew Owen, Ruben C Hartkoorn, Saye Khoo, et al.
Clinical Pharmacokinetics
|
August 8, 2019
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine
Alison Boyle, Catherine E Moss, Catia Marzolini, et al.
Plos Computational Biology
|
January 31, 2019
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
Sulav Duwal, Laura Dickinson, Saye Khoo, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 282) with videos related to
Sort By:
Page
of 29
Antimicrobial Agents and Chemotherapy
|
February 15, 2017
Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat <i>In Vitro</i>
Owain Roberts, Saye Khoo, Andrew Owen, et al.
Drugs
|
December 15, 2010
Grapefruit-drug interactions
Kay Seden, Laura Dickinson, Saye Khoo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 16, 2024
Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir
Catia Marzolini, Sara Gibbons, Daniel Seddon, et al.
The Journal of Antimicrobial Chemotherapy
|
October 13, 2006
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
Gerald Friedland, Saye Khoo, Christopher Jack, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2011
Should we switch to a 50-mg boosting dose of ritonavir for selected protease inhibitors?
Andrew Hill, Saye Khoo, Marta Boffito, et al.
Plos Computational Biology
|
June 15, 2018
Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes
Sulav Duwal, Laura Dickinson, Saye Khoo, et al.
International Journal of STD & AIDS
|
September 27, 2013
An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database)
Mohammed I Danjuma, Nurul H Mohamad-Fadzillah, Saye Khoo
AIDS (London, England)
|
October 3, 2003
Expression of P-glycoprotein, multidrug-resistance proteins 1 and 2 in CEM, CEM(VBL), CEM(E1000), MDCKII(MRP1) and MDCKII(MRP2) cell lines
Andrew Owen, Ruben C Hartkoorn, Saye Khoo, et al.
Clinical Pharmacokinetics
|
August 8, 2019
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine
Alison Boyle, Catherine E Moss, Catia Marzolini, et al.
Plos Computational Biology
|
January 31, 2019
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
Sulav Duwal, Laura Dickinson, Saye Khoo, et al.
Page
of 29